Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (161-170 of 359) with videos related to

Pageof 36
Sort By:
European Urology|July 5, 2011
A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomyJan Schmitges, Quoc-Dien Trinh, Firas Abdollah, et al.
Urology|November 18, 2008
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy seriesHendrik Isbarn, Claudio Jeldres, Lars Budäus, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2014
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletionsKatharina Grupp, Julia Wilking, Kristina Prien, et al.
Molecular Cancer|October 18, 2011
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylationRamesh Ummanni, Edgar Jost, Melanie Braig, et al.
European Urology|May 27, 2008
Molecular cancer phenotype in normal prostate tissueThorsten Schlomm, Olaf J C Hellwinkel, Andreas Buness, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
Cancers|December 22, 2019
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical ProstatectomyRun Shi, Xuanwen Bao, Joachim Weischenfeldt, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based studyAlexandre Larouche, Andreas Becker, Jonas Schiffmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2020
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approachPaul V Ritschl, Nora Nevermann, Leke Wiering, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
Pageof 36

Showing results (161-170 of 359) with videos related to

Sort By:
Pageof 36
European Urology|July 5, 2011
A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomyJan Schmitges, Quoc-Dien Trinh, Firas Abdollah, et al.
Urology|November 18, 2008
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy seriesHendrik Isbarn, Claudio Jeldres, Lars Budäus, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2014
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletionsKatharina Grupp, Julia Wilking, Kristina Prien, et al.
Molecular Cancer|October 18, 2011
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylationRamesh Ummanni, Edgar Jost, Melanie Braig, et al.
European Urology|May 27, 2008
Molecular cancer phenotype in normal prostate tissueThorsten Schlomm, Olaf J C Hellwinkel, Andreas Buness, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
Cancers|December 22, 2019
A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical ProstatectomyRun Shi, Xuanwen Bao, Joachim Weischenfeldt, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 16, 2014
Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based studyAlexandre Larouche, Andreas Becker, Jonas Schiffmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2020
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approachPaul V Ritschl, Nora Nevermann, Leke Wiering, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
Pageof 36